Aaron Chesnut

Aaron Chesnut joined Currax Pharmaceuticals LLC in 2021 as Vice President of Technical Operations, bringing over 20 years of strategic and operational experience in global biopharmaceuticals, medical devices, biotech and clinical research. He has implemented best practices in operations, engineering, quality, validation, clinical trials, manufacturing, laboratory testing, supply chain and regulatory affairs. Additionally, Aaron has managed the development, tech transfer, licensure and operations of numerous drug and biologic products.
 
Aaron has extensive experience in technical operations, including serving as Site Head of Quality at Allergan’s Biologic Drug Substance BLI facility for the manufacture of BOTOX®. He also led the design, build, qualification and licensure of pharmaceutical manufacturing facilities, including Genentech’s Oceanside Drug Substance/API facility and their Oregon Aseptic Drug Product facility.

Before joining Currax, Aaron was the Owner and Principal Consultant for Foundation Solutions GxP and has held senior roles at Prolacta Bioscience as Director of Quality Control, Senior Director of Quality & MSAT at PMI BioPharma Solutions and management roles at BiogenIDEC (acquired by Genentech) and Baxter BioScience.
 
Prior to entering the pharmaceutical industry, Aaron spent three years with NASA, working with a research team that investigated the biologic impact of ionizing radiation on the human body to support deep space travel.

Aaron received his Bachelor of Science in Biochemistry from the University of California.